Seres Therapeutics, Inc. (MCRB)
5.28
-0.28
(-5.04%)
USD |
NASDAQ |
Sep 09, 16:00
5.28
0.00 (0.00%)
After-Hours: 18:10
Seres Therapeutics Total Assets (Quarterly) : 101.59M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 101.59M |
| March 31, 2026 | 117.62M |
| December 31, 2025 | 138.19M |
| September 30, 2025 | 143.47M |
| June 30, 2025 | 143.80M |
| March 31, 2025 | 164.18M |
| December 31, 2024 | 139.81M |
| September 30, 2024 | 178.74M |
| June 30, 2024 | 321.73M |
| March 31, 2024 | 341.26M |
| December 31, 2023 | 358.60M |
| September 30, 2023 | 367.70M |
| June 30, 2023 | 406.39M |
| March 31, 2023 | 270.19M |
| December 31, 2022 | 348.78M |
| September 30, 2022 | 311.87M |
| June 30, 2022 | 273.20M |
| March 31, 2022 | 319.89M |
| December 31, 2021 | 354.86M |
| September 30, 2021 | 396.29M |
| June 30, 2021 | 269.65M |
| March 31, 2021 | 305.70M |
| December 31, 2020 | 342.94M |
| Date | Value |
|---|---|
| September 30, 2020 | 356.20M |
| June 30, 2020 | 100.68M |
| March 31, 2020 | 110.62M |
| December 31, 2019 | 132.44M |
| September 30, 2019 | 124.15M |
| June 30, 2019 | 146.09M |
| March 31, 2019 | 107.04M |
| December 31, 2018 | 120.47M |
| September 30, 2018 | 109.04M |
| June 30, 2018 | 132.95M |
| March 31, 2018 | 159.43M |
| December 31, 2017 | 189.52M |
| September 30, 2017 | 211.88M |
| June 30, 2017 | 216.34M |
| March 31, 2017 | 244.85M |
| December 31, 2016 | 272.65M |
| September 30, 2016 | 297.51M |
| June 30, 2016 | 306.22M |
| March 31, 2016 | 324.47M |
| December 31, 2015 | 216.90M |
| September 30, 2015 | 227.04M |
| June 30, 2015 | 101.28M |
| March 31, 2015 | 108.63M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 67.05M |
| Shareholders Equity (Quarterly) | 34.53M |
| Debt to Equity Ratio | 1.640 |
| Current Ratio | 2.114 |
| Net Debt Paydown Yield | 8.49% |